icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
16 Sep, 2020 16:08

Sputnik V to lift off for India: Russia will help supply 100 MILLION doses of pioneering coronavirus vaccine to New Delhi

Sputnik V to lift off for India: Russia will help supply 100 MILLION doses of pioneering coronavirus vaccine to New Delhi

Russia’s Sputnik V Covid-19 vaccine will be clinically trialed and distributed in India, with deliveries expected to begin later this year, according to the Russian Direct Investment Fund (RDIF), which bankrolled its development.

As soon as the vaccine is granted regulatory approval in India, Russia will help supply 100 million doses to the Asian nation, the RDIF said in a statement on Wednesday. It will partner with Hyderabad-based pharmaceutical giant Dr Reddy's. 

“India is amongst the most severely impacted countries from COVID 19 and we believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against COVID 19,” RDIF CEO Kirill Dmitriev explained.

Also on rt.com Sputnik V launched: Russia dispatches first batches of pioneering Covid-19 vaccine to all of its 85 regions

Deliveries of the vaccine formula could begin in the latter part of 2020 — as soon as the trials and all due legal procedures are completed by Indian regulators. India will conduct clinical trials of the vaccine, a Dr Reddy’s representative said, expressing hope the medicine will show solid results. 

“We are pleased to partner with RDIF to bring the vaccine to India. The Phase I and II results have shown promise, and we will be conducting Phase-III trials in India to meet the requirements of the Indian regulators,” Co-Chairman and Managing Director of Dr Reddy’s G V Prasad outlined, adding that the Sputnik V vaccine “could provide a credible option” in the country’s fight against the virus.

Russia was the first country to register a vaccine against the coronavirus which has caused international devastation since the beginning of the year. The formula, based on the human adenoviral vectors platform, was unveiled early in August. 

Also on rt.com Western pharma is ‘all about profit’: Philippines’ Duterte vows to solely procure coronavirus vaccines from Russia & China

India, alongside Brazil and the US, remains one of the worst coronavirus-affected nations in the world. The country surpassed the 5 million mark of registered Covid-19 cases on Wednesday, while more than 82,000 people have succumbed to the dreaded disease, according to the latest figures compiled by Johns Hopkins University.

Globally, more than 29.6 million people have contracted Covid-19 and some 935,000 have died.

Think your friends would be interested? Share this story!